Ozempic (a GLP-1 receptor agonist) works by mimicking a hormone that increases insulin production and decreases sugar production in the liver
Sobos approach to weight loss is built around the full patient, not only the number on the scale
It has the longest track record, the most extensive post-market safety data, cardiovascular outcome evidence, and broad availability
Unfortunately, in terms of both patient and healthcare provider perspectives, injection-related problems negatively affect the overall number of shots that patients with diabetes are willing to take, so that in some studies half of the patients reported mentioning such problems to their healthcare providers without getting any solution against the associated pain and bruising [6, 16, 17]
Winning post-LoE will require precision, agility, and a compelling value narrative not legacy strength but adaptive leadership